A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
NCT ID: NCT06327906
Last Updated: 2024-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6000 participants
OBSERVATIONAL
2023-11-15
2029-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Development and Its Influencing Factors in Premature Infants With Chronic Lung Disease
NCT00155831
A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China
NCT02831010
Development, ADL, Participation, and Quality of Life in Preterm Infants: A Longitudinal Follow Up Study
NCT05498753
The Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years
NCT05040542
Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months
NCT06662045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The living area is Jinan City and its surrounding areas in Shandong Province, which is convenient for follow-up.
Exclusion Criteria
* Psychological diseases
* History of craniocerebral trauma or brain organic disease ④Major physical diseases ⑤Visual and auditory disorders ⑥ Epilepsy ⑦Intellectual disabilities
1 Minute
42 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
cao aihua, post-doctoral
Role: PRINCIPAL_INVESTIGATOR
Qilu Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital of Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
zhu mengna, postgraduate
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
zhu mengna
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
qilu000002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.